Cargando…
IL-2 analogues: novel agents circumventing the expansion of T regulatory cells while promoting NK cell activation during IL-2 therapy
Autores principales: | Sim, Geok Choo, Grimm, Elizabeth, Dai, ZhiMin, Overwijk, Willem, Hwu, Patrick, Radvanyi, Laszlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991370/ http://dx.doi.org/10.1186/2051-1426-1-S1-P89 |
Ejemplares similares
-
Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2
por: Sim, Geok Choo, et al.
Publicado: (2016) -
IL-1-dependent cartilage damage in a macrophage-driven arthritis model can be circumvented by T cell IL-17
por: Koenders, MI, et al.
Publicado: (2004) -
Myc controls NK cell development, IL-15-driven expansion, and translational machinery
por: Khameneh, Hanif J, et al.
Publicado: (2023) -
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
por: Ojo, Evelyn O., et al.
Publicado: (2019) -
IL-2–dependent adaptive control of NK cell homeostasis
por: Gasteiger, Georg, et al.
Publicado: (2013)